Markets›Health care›JNJ

Johnson & Johnson

JNJ
271.22
+0.54 (+0.20%)
Closing price for Sep 25, 2026 from Polygon.io

Valuation

Market value653.61B
Enterprise value682.23B
Price to earnings (P/E)31.5
Price to sales6.7
Price to book7.7
Free cash flow yield3.4%

Profitability (last 12 months)

Revenue97.93B
Net income21.04B
Gross margin67.9%
Net margin21.5%
Return on equity24.8%
Return on assets10.5%

Growth (last fiscal year, FY 2025)

Revenue growth+6.0%
EPS growth+90.5%

Balance sheet (latest quarter)

Cash and equivalents20.42B
Total debt49.04B
Debt to equity0.58
Current ratio1.09

Per share and dividends

EPS, diluted (last 12 months)8.62
Shares outstanding2.41B
Dividends paid (last 12 months)None

Trading

Price271.22
52-week high281.07
52-week low179.80
1-year price change+49.33%
Average volume (3 months)7.05M
Beta against the S&P 500 (1 year)-0.17

Calculated from Johnson & Johnson's SEC filings (latest quarter ending Jun 28, 2026) and the price above. "Last 12 months" adds up the four most recent quarters. Beta compares one year of daily returns with the S&P 500 (SPY). Dividends from Polygon.io or Nasdaq.